Self-Reported Cervical Cancer Screening by Year, New Jersey, 2012 to 2020
Indicator Report Data View Options
Why Is This Important?
Cervical cancer is one of the most curable cancers if detected early through routine screening. Almost all cases of cervical cancer are caused by infection with high-risk types of the human papillomavirus (HPV). The HPV vaccine protects against the HPV types that most often cause cervical cancer. Women who have had an HPV vaccine still need to have routine Pap smears because the vaccine does not fully protect against all the strains of the virus and other risk factors that can cause cervical cancer. HPV is transmitted through sexual contact. Any woman who is sexually active is at risk for developing cervical cancer. Other risk factors include giving birth to many children, having sexual relations at an early age, having multiple sex partners or partners with many other partners, cigarette smoking, and use of oral contraceptives. The US Preventive Services Task Force (USPSTF) recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting).
Definition
Estimated percentage of women ages 21-65 years who have had a Pap test in the past three years. All prevalence estimates are age-adjusted to the U.S. 2000 standard population.
Data Notes
Data have been age-adjusted to the U.S. 2000 standard population.Data Source
Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health(http://www.nj.gov/health/chs/njbrfs/)
How the Measure is Calculated
Numerator:
The number of women ages 21-65 years who reported having a Pap test in the last three years.Denominator:
The total number of female survey respondents ages 21-65 years excluding those who responded "don't know" or "refused" to the numerator question.
Data Issues
Data from the New Jersey Behavioral Risk Factor Survey are intended to be representative of all non-institutionalized adult residents of New Jersey. Due to resource issues, however, adults with limited personal access to phone service or limited command of either English or Spanish are not represented. As with all surveys, also, some error results from nonresponse (e.g., refusal to participate in the survey or to answer specific questions), and faulty measurement (e.g., responses affected by social desirability or recall error). Data collection procedures intended to minimize such errors include the use of strict calling protocols, good questionnaire design, standardization of interviewer behavior, interviewer training, and frequent, on-site interviewer monitoring and supervision. Statistical weighting procedures are also used to minimize the potential impact of disproportionate representation of demographic subgroups defined in terms of age, sex, race, ethnicity, education level, marital status, home ownership, and county of residence. (See also [[a href="query/BRFSSQueryTechNotes.html" Behavioral Risk Factor Survey Data Description and Technical Notes]].)Related Health Objectives and Indicators
Health Initiative: HP2030
Healthy People 2030 Objective C-09
U.S. Target: Increase the proportion of females aged 21 to 65 years who receive a cervical cancer screening to 79.2 percent (age-adjusted) by 2030
https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer/increase-proportion-females-who-get-screened-cervical-cancer-c-09
Health Initiative: HP2020
Healthy People 2020 Objective C-15
U.S. Target: Increase the proportion of females aged 21 to 65 years who receive cervical cancer screening to 93.0 percent (age-adjusted) by 2020
https://www.healthypeople.gov/2020/topics-objectives/topic/cancer
Health Initiative: HNJ2020
Healthy NJ 2020 Objective CA-14
NJ Target: Increase cervical cancer screening to 93.6 percent (age-adjusted) for the total population, 79.8% for Asians, 99.3% for Blacks, 94.7% for Hispanics, and 94.9% for Whites by 2020
https://www.nj.gov/health/chs/hnj2020/topics/cancer.shtml
Health Initiative: CDI
Chronic Disease Indicator CAN10
Description: Cervical cancer screening among women aged 21-65 years
https://www.cdc.gov/cdi/indicator-definitions/cancer.html
Health Initiative: EPHT
Environmental Public Health Tracking Indicator PV-184
Description: Prevalence among adults of health insurance, dental visits, mammography, cervical cancer screening, colorectal cancer screening, cholesterol screening
https://ephtracking.cdc.gov/indicatorPages?selectedContentAreaAbbreviation=13&selectedIndicatorId=184